HKBU Invention 浸大創科 | A Novel Herbal Formulation (CDD-2103) for Remission Maintenance of UC

A Novel Herbal Formulation (CDD-2103) for Remission Maintenance of Ulcerative Colitis
一種針對潰瘍性結腸炎緩解期的創新植物藥（CDD-2103）

Inventors: Prof. Zhaoxiang BIAN, MH, Director, Centre for Chinese Herbal Medicine Drug Development Limited, Associate Vice-President (Clinical Chinese Medicine) of HKBU, Prof. Hoey TAN, Assistant Professor, Centre for Chinese Herbal Medicine Drug Development Limited
發明人：協理副校長（中醫藥發展）兼中藥創新研發中心總裁卞兆祥教授、中藥創新研發中心助理教授陳可瑜教授

The herbal formulation CDD-2103, developed based on years of clinical experience, is designed to maintain remission in ulcerative colitis patients. It has recently been authorised by the National Medical Products Administration of China for clinical trials.

中藥配方CDD-2103是基於多年的臨床經驗和研究開發的，專門針對維持潰瘍性結腸炎患者的緩解期。該配方獲得了中國國家藥品監督管理局的臨床試驗許可，為其未來的臨床應用提供了重要的支持。